Old Web
English
Sign In
Acemap
>
Paper
>
PCN56 COST-EFFECTIVENESS OF TEMSIROLIMUS FOR METASTIC RENAL-CELL CARCINOMA AND POOR PROGNOSIS PATIENTS IN MEXICO
PCN56 COST-EFFECTIVENESS OF TEMSIROLIMUS FOR METASTIC RENAL-CELL CARCINOMA AND POOR PROGNOSIS PATIENTS IN MEXICO
2011
H. Arreola Ornelas
Aa Rosado-Buzzo
Mdl García-Mollinedo
L. Camacho
J.F. Mould Quevedo
E. Muciño-Ortega
R.M. Galindo-Suárez
Keywords:
Intensive care medicine
Renal cell carcinoma
Temsirolimus
Medicine
Oncology
Internal medicine
poor prognosis
cost effectiveness
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]